NO975679L - Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer - Google Patents

Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer

Info

Publication number
NO975679L
NO975679L NO975679A NO975679A NO975679L NO 975679 L NO975679 L NO 975679L NO 975679 A NO975679 A NO 975679A NO 975679 A NO975679 A NO 975679A NO 975679 L NO975679 L NO 975679L
Authority
NO
Norway
Prior art keywords
preparation
monosubstituted
cyclic urea
disubstituted
unsymmetrical cyclic
Prior art date
Application number
NO975679A
Other languages
English (en)
Norwegian (no)
Other versions
NO975679D0 (no
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of NO975679D0 publication Critical patent/NO975679D0/no
Publication of NO975679L publication Critical patent/NO975679L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO975679A 1995-06-07 1997-12-05 Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer NO975679L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
PCT/US1996/009021 WO1996040652A1 (en) 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas

Publications (2)

Publication Number Publication Date
NO975679D0 NO975679D0 (no) 1997-12-05
NO975679L true NO975679L (no) 1998-02-02

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975679A NO975679L (no) 1995-06-07 1997-12-05 Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer

Country Status (26)

Country Link
US (1) US5532357A (et)
EP (2) EP1029859A1 (et)
JP (1) JPH11506779A (et)
KR (1) KR19990022467A (et)
CN (1) CN1192209A (et)
AR (1) AR002384A1 (et)
AU (1) AU704535B2 (et)
BR (1) BR9609493A (et)
CA (1) CA2223391A1 (et)
CZ (1) CZ381997A3 (et)
EA (1) EA000363B1 (et)
EE (1) EE9700330A (et)
HR (1) HRP960259A2 (et)
HU (1) HUP9900913A2 (et)
IL (1) IL122424A0 (et)
LT (1) LT4381B (et)
LV (1) LV12045B (et)
MX (1) MX9709652A (et)
NO (1) NO975679L (et)
NZ (1) NZ309648A (et)
PL (1) PL323993A1 (et)
SI (1) SI9620077A (et)
SK (1) SK164397A3 (et)
TW (1) TW358091B (et)
WO (1) WO1996040652A1 (et)
ZA (1) ZA964847B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
BR9712910A (pt) * 1996-11-08 2000-03-21 Du Pont Pharm Co ra o tratamento de infecção por hiv
JP2001518094A (ja) * 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Hivプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US6218534B1 (en) 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
WO2000000479A1 (en) * 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
AU5588400A (en) 1999-05-26 2000-12-18 Du Pont Pharmaceuticals Company 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
US7015214B2 (en) * 2001-03-28 2006-03-21 Bristol-Myers Squibb Pharma Company Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
US20080033167A1 (en) * 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for synthesizing heterocyclic therapeutic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
EP0765873B1 (en) * 1991-10-11 2002-04-17 Dupont Pharmaceuticals Company Cyclic ureas and analogues useful as retroviral protease inhibitors
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
ZA964847B (en) 1997-12-08
EA000363B1 (ru) 1999-06-24
WO1996040652A1 (en) 1996-12-19
MX9709652A (es) 1998-03-29
EA199800034A1 (ru) 1998-08-27
CA2223391A1 (en) 1996-12-19
BR9609493A (pt) 1999-03-02
EE9700330A (et) 1998-06-15
LV12045A (lv) 1998-05-20
KR19990022467A (ko) 1999-03-25
EP0837855A4 (en) 1998-09-02
LT4381B (lt) 1998-09-25
SK164397A3 (en) 2000-04-10
EP1029859A1 (en) 2000-08-23
LV12045B (en) 1998-09-20
AU704535B2 (en) 1999-04-29
EP0837855A1 (en) 1998-04-29
AU5986896A (en) 1996-12-30
TW358091B (en) 1999-05-11
CN1192209A (zh) 1998-09-02
CZ381997A3 (cs) 1999-01-13
NZ309648A (en) 1998-09-24
HUP9900913A2 (hu) 1999-09-28
AR002384A1 (es) 1998-03-11
PL323993A1 (en) 1998-04-27
IL122424A0 (en) 1998-06-15
SI9620077A (sl) 1998-08-31
LT97188A (en) 1998-04-27
JPH11506779A (ja) 1999-06-15
US5532357A (en) 1996-07-02
NO975679D0 (no) 1997-12-05
HRP960259A2 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
TW221811B (et)
ES2097448T3 (es) Sulfitos y sulfatos ciclicos de fructopiranosis con actividad anticonvulsiva.
DE69613985D1 (de) Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
NO975679L (no) Fremgangsmåte for fremstilling av N-monosubstituerte og N,N'-disubstituerte, usymmetriske, cykliske ureaer
MX9700564A (es) Derivados de benzoilo y sintesis de los mismos.
DE69615802D1 (de) Heterocyclische substituierte Benzofuran-Harnstoffe
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
BR0009411A (pt) Composto de anilina substituìda, e, processo para a preparação e uso de compostos
MY113863A (en) Method for preparing n, n' - disubstituted cyclic ureas
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
ATE126532T1 (de) Modifizierte protease, verfahren zu deren herstellung und diese enthaltende kosmetische zusammensetzungen.
NO904801L (no) Fremgangsmaate for fremstilling av acat-inhibitorer.
YU63696A (sh) Novi fenilamidin-derivati, postupci za njihovo pripremanje i njihova primena kao lekova
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
BR9506977A (pt) Processo para sintetizar um epóxido e composto
DK0998471T3 (da) Heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
HU910784D0 (en) Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance
TR199701298T1 (xx) Tetralinler.
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
NO20012492D0 (no) Fremgangsmåte for fremstilling av N-alkyl-N'-nitroguanidin
TR200100906T2 (tr) Trombin inhibitörleri olarak benzamid türevleri
TR200402685T4 (tr) Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application